Tag Archives: HIV

Medicine Patent Pool’s agreement with Gilead: Is it really a fair deal?

Posted on July 21, 2011 by

Recently, Medicine Patent Pool signed its first agreement with pharmaceutical company Gilead for the production of the HIV medicines tenofovir, emtricitabine, cobicistat, and elvitegravir as well as a combination of these products in a single pill known as the “Quad.” Click … Continue reading →

Posted in Generic drug, HIV/Aids, Medicine Patent Pool | Tagged , , , , , , | Leave a comment

Global Access Licensing as means to increase access to medicines

Posted on July 15, 2011 by

Read here an interesting blog article by UAEM suggesting Global Access Licensing as means for ensuring that public funded research on medical innovation reaches to people living in the developing countries on affordable prices. Global Access Licensing would allow generic … Continue reading →

Posted in Generic drug, HIV/Aids | Tagged , , , , , | Leave a comment

Vietnam and the Trans-Pacific Partnership Agreement

Posted on June 22, 2011 by

The Trans-Pacific Partnership free trade agreement being currently negotiated is proving to be retrograde to the fight against HIV in Vietnam. According to a June 16 article in the Public Citizen: The leaked U.S. proposal for the intellectual property chapter of the … Continue reading →

Posted in data exclusivity, Generic drug, HIV/Aids, TPPA, Trans-Pacific Partnership Agreement, TRIPS plus, Uncategorized | Tagged , , , , | 1 Comment

AIDS Fight Hits Hurdle Over Funding

Posted on May 30, 2011 by

Global Economy Crimps Contributions to Developing Nations for Drugs Recently Shown to Curb Spread  Wall Street Journal By BETSY MCKAY And MARK SCHOOFS In advance of a major United Nations meeting on the global AIDS epidemic, public-health leaders face a … Continue reading →

Posted in HIV/Aids, UN General Assembly HLM | Tagged , , , , | 1 Comment